Literature DB >> 19145462

Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis.

Robert Nason1, Jae Y Jung, Richard A Chole.   

Abstract

Osteoclasts are the only cells capable of carrying out bone resorption and therefore are responsible for the osteolysis seen in infectious diseases such as chronic otitis media and infected cholesteatoma. Pseudomonas aeruginosa is the most common organism isolated from these infectious middle ear diseases. In this study, we examined the mechanisms by which P. aeruginosa lipopolysaccharide (LPS) stimulates osteoclastogenesis directly from mononuclear osteoclast precursor cells. Osteoclast precursors demonstrated robust, bone-resorbing osteoclast formation when stimulated by P. aeruginosa LPS only if previously primed with permissive, sub-osteoclastogenic doses of receptor activator of NF-kappaB ligand (RANKL), suggesting that LPS is osteoclastogenic only during a specific developmental window. Numerous LPS-elicited cytokines were found to be released by osteoclast precursors undergoing P. aeruginosa LPS-mediated osteoclast formation. Two lines of evidence suggest that several cytokines promote Oc formation in an autocrine/paracrine manner. First, inhibition of several cytokine pathways including TNF-alpha, IL-1, and IL-6 block the osteoclastogenesis induced by LPS. Secondly, increased expression of the receptors for TNF-alpha and IL-1 was demonstrated by real-time quantitative polymerase chain reaction. Such a mechanism has not previously been established and demonstrates the ability of osteoclast precursors to autonomously facilitate bone destruction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19145462      PMCID: PMC2674198          DOI: 10.1007/s10162-008-0153-8

Source DB:  PubMed          Journal:  J Assoc Res Otolaryngol        ISSN: 1438-7573


  38 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro.

Authors:  N J Horwood; J Elliott; T J Martin; M T Gillespie
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

Review 3.  Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.

Authors:  L C Hofbauer; A E Heufelder
Journal:  J Mol Med (Berl)       Date:  2001-06       Impact factor: 4.599

4.  Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts.

Authors:  Y Azuma; K Kaji; R Katogi; S Takeshita; A Kudo
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

5.  Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism.

Authors:  W Zou; I Hakim; K Tschoep; S Endres; Z Bar-Shavit
Journal:  J Cell Biochem       Date:  2001 Jun 26-Jul 25       Impact factor: 4.429

6.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

7.  Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.

Authors:  E M Gravallese; C Manning; A Tsay; A Naito; C Pan; E Amento; S R Goldring
Journal:  Arthritis Rheum       Date:  2000-02

8.  Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.

Authors:  Y H Zhang; A Heulsmann; M M Tondravi; A Mukherjee; Y Abu-Amer
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

9.  A 16-year survey of changes in bacterial isolates associated with chronic suppurative otitis media.

Authors:  T Nakagawa; O Yadohisa; S Komune; T Uemura
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

10.  Stimulation of osteoclastogenesis by enhanced levels of MIP-1alpha in BALB/c mice in vitro.

Authors:  Ji-Eun Lee; Hyun-Hee Shin; Eun-A Lee; Tien Van Phan; Hye-Seon Choi
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

View more
  14 in total

Review 1.  The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.

Authors:  Shumin Xie; Xiaoli Wang; Jihao Ren; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-16       Impact factor: 2.503

2.  Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.

Authors:  Wei Liu; Shumin Xie; Xing Chen; Xingwang Rao; Hongmiao Ren; Bing Hu; Tuanfang Yin; Yuyan Xiang; Jihao Ren
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 3.  Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms.

Authors:  Mohammed S AlQranei; Meenakshi A Chellaiah
Journal:  J Oral Biosci       Date:  2020-02-17

4.  N-Acetylcysteine Attenuates Lipopolysaccharide-Induced Osteolysis by Restoring Bone Remodeling Balance via Reduction of Reactive Oxygen Species Formation During Osteoclastogenesis.

Authors:  Guangqi Yan; Yan Guo; Jingwen Guo; Qiang Wang; Chunyu Wang; Xue Wang
Journal:  Inflammation       Date:  2020-08       Impact factor: 4.657

5.  Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.

Authors:  Kuen Yao Ho; Tai Sheng Yeh; Han Hsiang Huang; Kuo Feng Hung; Chee Yin Chai; Wan Tzu Chen; Shih Meng Tsai; Ning Chia Chang; Chen Yu Chien; Hsun Mo Wang; Yu Jen Wu
Journal:  Int J Mol Sci       Date:  2013-07-11       Impact factor: 5.923

6.  Use of ethanol extracts of Terminalia chebula to prevent periodontal disease induced by dental plaque bacteria.

Authors:  Jongsung Lee; Youn Hwa Nho; Seok Kyun Yun; Young Sun Hwang
Journal:  BMC Complement Altern Med       Date:  2017-02-16       Impact factor: 3.659

7.  Comparison of Titanium vs. Polycel Total Ossicular Replacement Prosthesis.

Authors:  Mohammad Faramarzi; Reza Jahangiri; Sareh Roosta
Journal:  Iran J Otorhinolaryngol       Date:  2016-03

8.  TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction.

Authors:  Yu Si; Yu Bin Chen; Sui Jun Chen; Yi Qing Zheng; Xiang Liu; Yi Liu; Huai Li Jiang; Guo Xu; Zhuo Hao Li; Qiu Hong Huang; Hao Xiong; Zhi Gang Zhang
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

9.  Identification of altered protein abundances in cholesteatoma matrix via mass spectrometry-based proteomic analysis.

Authors:  Derrick R Randall; Phillip S Park; Justin K Chau
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-11-25

Review 10.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.